Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Business Segments Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 03:58:53 2024-12-06 pm EST 		5-day change 1st Jan Change
0.1750 CAD +9.38% Intraday chart for Entheon Biomedical Corp. +25.00% +75.00%
Dec. 02 Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding CI
Oct. 24 Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 CI

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (CAD)
Fiscal Period: November20192020202120222023

Biological Products

     

Acquisition, Exploration and Development of Mining Properties

- - 21.67K 190K 250K

Total Assets

137K 4.47M 9.98M 769K 401K

CAPEX

- -9.03K -97.97K - -

EBT

-667K -4.38M -8.89M -2.06M -300K

Gross Profit

- - 9.13K - -

D&A

- 2.72K 35.7K -648K -

Net Income

-667K -4.38M -8.89M -8.52M -300K

Geographical Revenue Distribution History

Geographical breakdown of sales (CAD)
Fiscal Period: November20192020202120222023

Canada

- - 21.67K 190K 250K

Total Assets

137K 4.47M 9.98M 769K 401K

D&A

- 2.72K 35.7K -648K -

CAPEX

- -9.03K -97.97K - -

Gross Profit

- - 9.13K - -

Net Income

-667K -4.38M -8.89M -8.52M -300K

EBT

-667K -4.38M -8.89M -2.06M -300K
  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. Financials Entheon Biomedical Corp.
  5. Business Segments